Badii Amamou, S. Fathallah, Dhekra Ammar, A. Mhalla, F. Zaafrane, L. Gaha
{"title":"Impact of demographic, clinical and psychological variables of patients and caregivers on the perception of burden among the family caregivers of patients with cancer","authors":"Badii Amamou, S. Fathallah, Dhekra Ammar, A. Mhalla, F. Zaafrane, L. Gaha","doi":"10.15761/ICST.1000303","DOIUrl":"https://doi.org/10.15761/ICST.1000303","url":null,"abstract":"The study aims were to assess the level of burden among caregivers of patients diagnosed with cancer and to examine patient and caregiver variables associated with high levels of burden. A descriptive cross sectional study was performed at the Psychiatric Department in the University Hospital of Monastir, Tunisia. The study included a total of 138 dyads of patients and their corresponding family caregivers. The dyads were convoked then examined. The data were assembled using questionnaires elaborated by the research team and caregiver burden was measured with the Zarit Burden Interview. Patients completed the Hospital Anxiety and Depression Scale and the KATZ Index of Activities of Daily Living. About one third of the caregivers experienced high levels of burden. The scores at the Zarit Burden Interview ranged from 15 to 70 and mean score was 48.7 (SD =18.2). This negative outcome of caregiving was found to be related to both patients’ and caregivers’ variables. Statistically, the factors associated to high levels of burden among family caregivers that are linked to the patient’s profile were: male gender, age between 61 and 70 years old, having other medical morbidities, necessitating pre and post-operative chemotherapy, having intermediate to high levels of anxious or depressive symptoms and a severe functional impairment. Caregivers who helped their patients to accomplish many daily activities were found to be high-burdened. The caregiver variables that were found to be related to high levels of burden among caregivers were: male gender, age between 40 and 59 years old, employed full-time status, being the child of the patient, having another member of the family needing daily care, caregiving period more than one year, and not resorting to a professional healthcare at home. The current study demonstrates the importance of a systematic assessment and early intervention procedures needed in order to detect vulnerable caregivers.","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67475846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Absolute quantification of stool-based colon cancer microRNAs by chip-based digital (d)PCR","authors":"Farid E. Ahmed","doi":"10.15761/icst.1000304","DOIUrl":"https://doi.org/10.15761/icst.1000304","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67476044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non small cell lung cancer with targetable driver alterations: Imaging perspective","authors":"Eric W. Zhang, Subba R. Digumarthy","doi":"10.15761/icst.1000324","DOIUrl":"https://doi.org/10.15761/icst.1000324","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67477013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amanda Graul-Conroy, Margo Hoover-Regan, Kenneth B DeSantes, Paul M Sondel, Natalie S Callander, Walter L Longo, William E Fahl
{"title":"Reduction in oral mucositis severity using a topical vasoconstrictor: A case report of three bone marrow transplant patients.","authors":"Amanda Graul-Conroy, Margo Hoover-Regan, Kenneth B DeSantes, Paul M Sondel, Natalie S Callander, Walter L Longo, William E Fahl","doi":"10.15761/ICST.1000293","DOIUrl":"https://doi.org/10.15761/ICST.1000293","url":null,"abstract":"<p><strong>Background: </strong>Grade 3 oral mucositis (OM) is historically observed in >90% of bone marrow transplant patients who received the cyclophosphamide + total body irradiation (CY+TBI) conditioning regimen. It was previously shown that orotopically applied adrenergic vasoconstrictor prevented up to 100% of radiation-induced oral mucositis in two preclinical animal models.</p><p><strong>Methods: </strong><i>A</i>drenergic vasoconstrictor (i.e., phenylephrine in an aqueous-alcohol NG11-1 formulation) was orotopically applied to three patients (ages 24-29) who received the CY+TBI conditioning regimen; they were compared to five matched controls who received no orotopical vasoconstrictor. All patients received the CY+TBI conditioning regimen for acute lymphoblastic leukemia within the University of Wisconsin Adult Bone Marrow Transplant Program. Over the seven-day Cy+TBI conditioning regimen, 20 min before each treatment, either radiation or chemotherapy, vasoconstrictor was applied topically to the oral cavity, and patients then received either 1.5 Gy whole-body radiation or IV cyclophosphamide.</p><p><strong>Results: </strong>OM severity was scored over a three-week period using: i) physican assessments, ii) daily photos of the oral cavity, iii) oral pain and oral function score sheets, and iv) recorded narcotic consumption. Both \"Grade 3 OM\" duration and \"any OM\" duration in vasoconstrictor-treated patients were substantially lower than for the five control patients. Though nasogastric tube or total parenteral nutrition were used in 3 out of 5 control patients, there was no use of these supportive care measures in the three vasoconstrictor-treated patients.</p><p><strong>Conclusion: </strong>Orotopically applied NG11-1 vasoconstrictor formulation substantially reduced the incidence and severity of \"Grade 3\" and \"any\" oral mucositis when compared to matched control patients, all of whom received the same CY+TBI conditioning regimen. The liquid orotopical formulation was easily tolerated by patients both in its ease of use and lack of side effects.</p>","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37453464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Translocations involving ETS family proteins in human cancer.","authors":"Elizabeth A Fry, Ali Mallakin, Kazushi Inoue","doi":"10.15761/ICST.1000281","DOIUrl":"10.15761/ICST.1000281","url":null,"abstract":"<p><p>The ETS transcription factors regulate expression of genes involved in normal cell development, proliferation, differentiation, angiogenesis, and apoptosis, consisting of 28 family members in humans. Dysregulation of these transcription factors facilitates cell proliferation in cancers, and several members participate in invasion and metastasis by activating certain gene transcriptions. ETS1 and ETS2 are the founding members of the ETS family and regulate transcription by binding to ETS sequences. Three chimeric genes involving <i>ET</i>S genes have been identified in human cancers, which are <i>EWS-FLI1</i> in Ewing's sarcoma, <i>TMPRSS2-ERG</i> in prostate cancer, and <i>ETV6-RUNX1</i> in acute lymphocytic leukemia. Although these fusion transcripts definitely contribute to the pathogenesis of the disease, the impact of these fusion transcripts on patients' prognosis is highly controversial. In the present review, the roles of ETS protein translocations in human carcinogenesis are discussed.</p>","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287620/pdf/nihms-988104.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36774287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Secreted glycoprotein YKL-40: A potential cancer biomarker and therapeutic target","authors":"R. Shao","doi":"10.15761/ICST.1000268","DOIUrl":"https://doi.org/10.15761/ICST.1000268","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67474458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Durán, Pomuceno-Orduñez Jp, R. Martin, E. Silva, S. Montero, R. Mansilla, G. Cocho, J. Nieto-Villar
{"title":"Glucose starvation as cancer treatment: Thermodynamic point of view","authors":"I. Durán, Pomuceno-Orduñez Jp, R. Martin, E. Silva, S. Montero, R. Mansilla, G. Cocho, J. Nieto-Villar","doi":"10.15761/ICST.1000276","DOIUrl":"https://doi.org/10.15761/ICST.1000276","url":null,"abstract":"To evaluate the effect of glucose deprivation on the robustness of cancer glycolysis, the total entropy production rate was calculated from the in silico modeling of the glycolytic network of HeLa cells grown under different glucose and oxygen conditions. It was shown that glucose deprivation had a deleterious effect for the cells grown under hypoglycemia and hypoxia and that the intracellular acidification therapy and the glucose deprivation treatment had synergic effects on the decrease of cancer glycolysis robustness. *Correspondence to: Ileana Durán, Department of Chemical-Physics, A. Alzola Group of Thermodynamics of Complex Systems M.V. Lomonosov Chemistry Chair, Faculty of Chemistry, University of Havana, Havana 10400, Cuba, E-mail: ileduranadn@gmail.com Nieto-Villar JM, Department of Chemical-Physics, A. Alzola Group of Thermodynamics of Complex Systems M.V. Lomonosov Chemistry Chair, Faculty of Chemistry, University of Havana, Havana 10400, Cuba, E-mail: nieto@fq.uh.cu Received: May 02, 2018; Accepted: May 28, 2018; Published: May 31, 2018 Introduction Cancer, the second leading cause of death worldwide [1], is a generic name given to a complex interaction network of malignant cells that have lost their specialization and control over normal growth [2]. This behavior stems from to the accumulation of multiple DNA mutations in specific genes called oncogenes and tumor suppressor genes [3]. The design and development of new cancer drugs may take several years and in most cases will only be effective for a fraction of patients with specific types of cancer. Therefore, it is important to develop complementary strategies that can be quickly translated into effective therapies [4]. Cancer cells are characterized for maintaining a high rate of glycolysis, thus converting glucose to lactate at high speed, even in the presence of oxygen. This phenomenon is known as “aerobic glycolysis” or “Warburg effect”. Numerous therapies against cancer are based on the inhibition of this metabolic network [5]. It is known that glucose deprivation has deleterious effects on cancer glycolysis which may even conduce to cell death [6]. Mutations and epigenetic modifications that increase growth and promote insensitivity to anti-growth signals in cancer cells, lead to the loss of appropriate responses to rapidly adapt to a variety of extreme environments including starvation [7]. Under challenging conditions such as starvation, normal cells reduce energy expenditure and divert it from growth to maintenance; thereby enhancing protection and survival [8]. However, the constitutive activation of oncoproteins can block entry into this protective mode in cancer cells; thus providing a method by which fasting induces protection in normal cells but not in oncogene-driven cancer cells, an effect called Differential Stress Resistance [4,9]. Hypoxia arises in tumors through the uncontrolled oncogene driven proliferation of cancer cells in the absence of an efficient vascula","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67474667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Saadani Ch, H. Baybay, Safae Zinoune, Z. Douhi, F. Mernissi
{"title":"Erysipelas of the upper extremity: About 25 cases of breast cancer with loco regional therapy","authors":"Saadani Ch, H. Baybay, Safae Zinoune, Z. Douhi, F. Mernissi","doi":"10.15761/ICST.1000284","DOIUrl":"https://doi.org/10.15761/ICST.1000284","url":null,"abstract":"Aim: The aim of this study was to evaluate the prevalence of erysipelas of the upper extremity in women treated for breast cancer. Methods: A study of 7-years retro-prospective study identifying 25 cases of erysipelas of the upper extremity following treatment for breast cancer; was carried out between March 2010 and December 2017 at the Hassan II hospital Fes, Morroco, we describe the clinical, therapeutic, and evolutionary aspects. Results: The mean age was of 48, 17 years. All patients had a breast surgery and lymphadenectomy. The erysipelas appeared with an average of 5.23 years after cancer treatment and was recurrent in seven cases. Lymphedema occurred in eighteen patients. The clinical aspect was an inflammatory plaque. The portal of entry was found in 73.91% of patients. The upper limb was affected in all cases. Involvement of the axillary folds or the chest was observed in 30.43%. Treatment with amoxicillin associated with clavulanic acid was undertaken for all patients. Conclusion: Lymphadenectomy and radiotherapy in breast cancer may lead to lymphedema, which can be evident or sometimes discrete. Those patients who developed erysipelas in our series usually fared well with treatment, but many had recurrences attributed to persistent lymphedema.","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67474977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HeberFERON, a promising choice for the treatment of basal cell carcinoma","authors":"I. B. Rivero","doi":"10.15761/ICST.1000292","DOIUrl":"https://doi.org/10.15761/ICST.1000292","url":null,"abstract":"In 2005, these efforts were crowned with the presentation of a patent describing the obtaining of a new formulation of IFNs, based on the synergism of the combination of the IFNs alpha 2b and gamma and in an ingenious work of identification of excipients, which allowed to obtain a new formulation of IFNs, unique in the world, with a stronger antitumor action than separately IFNs and more safely, during the treatment of patients [1].","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67475471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Keauna Braun, M. Chelberg, E. Hanke, Samantha J. Lefaive, L. Lenz, M. Wiggins
{"title":"Impact of a functional-based exercise program on fatigue, quality of life, and muscular endurance in cancer patients: A pilot study","authors":"Keauna Braun, M. Chelberg, E. Hanke, Samantha J. Lefaive, L. Lenz, M. Wiggins","doi":"10.15761/ICST.1000288","DOIUrl":"https://doi.org/10.15761/ICST.1000288","url":null,"abstract":"Background/Purpose: The purpose of this study is to investigate the impact of a functional-based exercise program on fatigue, quality of life, and muscular endurance in cancer patients. Methods: Eleven individuals from a Cancer Recovery & Fitness Program participated in this study. After each individual agreed to participate in the study, baseline measurements were taken for three specific muscular endurance exercises; modified biceps curl, modified sit-to-stand, and a modified chest press. Participants also filled out the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire on perceived quality of life at baseline testing, and the Fatigue Symptom Inventory (FSI) questionnaire on perceived fatigue every week after one exercise session. After attending the six-week program, the participants were retested using the same methods. Results: Dependent (paired) sample t-tests were used to determine if there were significant differences in ME and FACT-G test scores from pretest to post test. Since multiple t-tests were being analyzed, the Bonferroni correction was used to control for Type I error, which resulted in an adjusted p-value of .0125. Fatigue was tested using a repeated-measure ANOVA. Significant differences were found in the modified biceps curl (p = .005) and modified chest press tests (p = .004). No significant differences were found for the sit-to-stand test or the FSI and FACT-G questionnaires. Conclusion: A 6-week functional-based exercise program can have a significant impact on muscular endurance with cancer survivors in the area of biceps curls and chest press. *Correspondence to: Matthew S Wiggins, Department of Kinesiology, University of WisconsinEau Claire, 105 Garfield Ave., Eau Claire WI, 54701, USA, E-mail: wigginsm@uwec.edu","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67475523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}